2010
Exploring the impact of gender and reproductive status on outcomes in a randomized clinical trial of naltrexone augmentation of nicotine patch
Epperson CN, Toll B, Wu R, Amin Z, Czarkowski KA, Jatlow P, Mazure CM, O’Malley S. Exploring the impact of gender and reproductive status on outcomes in a randomized clinical trial of naltrexone augmentation of nicotine patch. Drug And Alcohol Dependence 2010, 112: 1-8. PMID: 20561758, PMCID: PMC2946976, DOI: 10.1016/j.drugalcdep.2010.04.021.Peer-Reviewed Original ResearchConceptsPlacebo groupStudy completersNaltrexone doseClinical trialsContinuous abstinenceOral naltrexone treatmentNicotine patch therapyNicotine replacement therapyInteractive voice responseRandomized clinical trialsMenstrual cycle statusEffect of doseNaltrexone augmentationNaltrexone groupAdverse eventsNaltrexone treatmentNicotine patchPatch therapyReplacement therapyQuit dayWeek 1AbstinenceDoseWomenLess adherent
2000
Adverse Life Events and Cognitive-Personality Characteristics in the Prediction of Major Depression and Antidepressant Response
Mazure CM, Bruce ML, Maciejewski PK, Jacobs SC. Adverse Life Events and Cognitive-Personality Characteristics in the Prediction of Major Depression and Antidepressant Response. American Journal Of Psychiatry 2000, 157: 896-903. PMID: 10831468, DOI: 10.1176/appi.ajp.157.6.896.Peer-Reviewed Original ResearchConceptsCognitive-personality stylesCognitive–personality characteristicsAdverse life eventsStressful life eventsMajor depressionLife eventsTreatment outcomesComparison subjectsDepressive onsetMultivariate modelCommunity comparison subjectsDSM-IV unipolar depressionDepressive symptom severityHealthy comparison subjectsEvent typesAntidepressant regimenAdverse eventsAntidepressant responseInterpersonal eventsAchievement eventsUnipolar depressionBetter outcomesEpisode onsetSymptom severityGroup status